Business · 15/05/2003Updated: 10/17/2026 · 1 min read
FDA Approves New Xylazine Dosage for Elk and Wild Deer Sedation
Summary
The FDA is amending its regulations to allow for the use of a 300mg/mL xylazine hydrochloride solution in elk and wild deer for sedation, with a shorter duration of analgesia, and includes a food safety warning for currently approved products.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →